Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYTOKINETICS INCCYTK · Entity 3528 | Director · President & CEO | October 12, 2026 | October 13, 2026 |
| Gamida Cell Ltd.GMDA · Entity 94655 | Director | February 08, 2023 | February 11, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYTOKINETICS INC
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 278,544 |
Ending reported balance
After 2026-10-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-12 · Exercise / conversion · Acquired 7,500 · Balance 286,044 Row 2 · 2026-10-12 · Sale · Disposed 7,500 · Balance 278,544 |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.60 · Expires 2027-02-28 | Direct | 141,745 |
Reported balance
After 2026-10-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-12 · Exercise / conversion · Disposed 7,500 · Balance 141,745 |
| Common StockSEC Table I · non-derivative | Indirectby Trust 1. Beneficial Ownership disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,083 F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
| Common StockSEC Table I · non-derivative | Indirectby Trust 2. Beneficial Ownership Disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,083 F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
Gamida Cell Ltd.
Report date February 08, 2023 · Filed February 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 96,500 |
Ending reported balance
After 2023-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-08 · Grant · Acquired 28,300 · Balance 82,300 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. Row 2 · 2023-02-08 · Grant · Acquired 14,200 · Balance 96,500 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 56,600 |
Reported balance
After 2023-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-08 · Grant · Acquired 56,600 · Balance 56,600 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 28,300 |
Reported balance
After 2023-02-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-08 · Grant · Acquired 28,300 · Balance 28,300 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.
F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 200 | $14.80 | $2,960.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 9 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,385 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $14.75 | $1,475.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 8 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,585 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 300 | $14.73 | $4,417.50 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,685 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,300 | $14.70 | $19,110.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 800 | $14.68 | $11,740.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,285 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,200 | $14.65 | $17,580.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,085 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $14.63 | $1,462.50 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,285 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 400 | $14.60 | $5,840.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,385 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $14.55 | $1,455.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,785 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 177 | $14.20 | $2,513.40 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 12 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 405 | $13.90 | $5,629.50 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 11 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,062 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 500 | $13.88 | $6,937.50 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 10 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,467 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 695 | $13.85 | $9,625.75 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 9 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,967 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.83 | $1,382.50 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 8 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,662 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,123 | $13.80 | $15,497.40 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,762 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 300 | $13.75 | $4,125.00 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 900 | $13.70 | $12,330.00 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,185 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.68 | $1,367.50 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,085 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 500 | $13.65 | $6,825.00 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,185 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.60 | $1,360.00 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,685 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.55 | $1,355.00 |
DisclosureSEC source: 0001061983-17-000044 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,785 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 01:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 309 | $12.20 | $3,769.80 |
DisclosureSEC source: 0001061983-17-000042 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 01:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $12.18 | $1,217.50 |
DisclosureSEC source: 0001061983-17-000042 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,194 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 01:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 3,091 | $12.15 | $37,555.65 |
DisclosureSEC source: 0001061983-17-000042 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,294 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 01:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,500 | $12.10 | $18,150.00 |
DisclosureSEC source: 0001061983-17-000042 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,385 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.85 | $1,385.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 10 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 400 | $13.80 | $5,520.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 9 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 800 | $13.75 | $11,000.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 8 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,385 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 200 | $13.70 | $2,740.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,185 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 700 | $13.65 | $9,555.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,385 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 800 | $13.60 | $10,880.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,085 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 932 | $13.55 | $12,628.60 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 500 | $13.50 | $6,750.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,817 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 468 | $13.45 | $6,294.60 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,317 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.40 | $1,340.00 |
DisclosureSEC source: 0001061983-17-000037 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,785 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 194,235 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-17-000012 · edgardoc.xml · derivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,235 Underlying: Common Stock · 194,235 shares Expires 2027-02-28 F4 · derivative.exercise_date: When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 10,765 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-17-000012 · edgardoc.xml · derivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,765 Underlying: Common Stock · 10,765 shares Expires 2027-02-28 F4 · derivative.exercise_date: When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021. Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 17,007 | $10.60 | $180,274.20 |
DisclosureSEC source: 0001061983-17-000012 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,768 Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 45,000 | $0.00 | $45.00 |
DisclosureSEC source: 0001061983-17-000012 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,775 Read SEC document |
| February 28, 2017 Filed Mar 3, 2017 00:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 60,000 | $0.00 | $60.00 |
DisclosureSEC source: 0001061983-17-000012 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,775 F1 · balance_after: The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/28/2018, 40% on 02/28/2019 and 20% on 02/28/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.